✦ LIBER ✦

Bivalirudin versus heparin and glycoprotein IIb/IIIa inhibition among patients with renal impairment undergoing percutaneous coronary intervention (a subanalysis of the REPLACE-2 trial)

✍ Scribed by Derek P. Chew; A. Michael Lincoff; Hitinder Gurm; Katherine Wolski; David J. Cohen; Tim Henry; Frederick Feit; Eric J. Topol

Book ID: 113441724
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 113 KB
Volume: 95
Category: Article
ISSN: 0002-9149
DOI: 10.1016/j.amjcard.2004.11.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Economic evaluation of bivalirudin with

Economic evaluation of bivalirudin with provisional glycoprotein IIB/IIIA inhibition versus heparin with routine glycoprotein IIB/IIIA inhibition for percutaneous coronary intervention: Results from the REPLACE-2 trial

✍ David J. Cohen; A. Michael Lincoff; Tara A. Lavelle; Huei-Ling Chen; Ameet Bakha 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Provisional glycoprotein IIb/IIIa blocka

Provisional glycoprotein IIb/IIIa blockade in a randomized investigation of bivalirudin versus heparin plus planned glycoprotein IIb/IIIa inhibition during percutaneous coronary intervention: Predictors and outcome in the Randomized Evaluation in Percutaneous coronary intervention Linking Angiomax to Reduced Clinical Events (REPLACE)–2 trial

✍ J. Emilio Exaire; Samuel M. Butman; Ramin Ebrahimi; Neal S. Kleiman; Robert A. H 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 179 KB

Comparison of Bivalirudin Versus Bivalir

Comparison of Bivalirudin Versus Bivalirudin Plus Glycoprotein IIb/IIIa Inhibitor Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitor in Patients With Acute Coronary Syndromes Having Percutaneous Intervention for Narrowed Saphenous Vein Aorto-Coronary Grafts (the ACUITY Trial Investigators)

✍ Dinesh Kumar; George Dangas; Roxana Mehran; Ajay Kirtane; Michel Bertrand; Ramin 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 152 KB

Safety and Efficacy of Bivalirudin With

Safety and Efficacy of Bivalirudin With and Without Glycoprotein IIb/IIIa Inhibitors in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: 1-Year Results From the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) Trial

✍ Harvey D. White; E. Magnus Ohman; A. Michael Lincoff; Michel E. Bertrand; Antoni 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 571 KB

Bleeding Risk and Outcomes of Bivalirudi

Bleeding Risk and Outcomes of Bivalirudin Versus Glycoprotein IIb/IIIa Inhibitors With Targeted Low-Dose Unfractionated Heparin in Patients Having Percutaneous Coronary Intervention for Either Stable or Unstable Angina Pectoris

✍ Daniel H. Steinberg; Palak Shah; Tim Kinnaird; Tina L. Pinto Slottow; Probal K. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 137 KB

Association Between Angiographic Complic

Association Between Angiographic Complications and Clinical Outcomes Among Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: An EARLY ACS (Early Glycoprotein IIb/IIIa Inhibition in Non–ST-Segment Elevation Acute Coronary Syndrome) Angiographic Substudy

✍ Yuri B. Pride; Satishkumar Mohanavelu; Cafer Zorkun; Vijayalakshmi Kunadian; Rob 📂 Article 📅 2012 🏛 American College of Cardiology 🌐 English ⚖ 385 KB